Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

Abstract:

:Intravenous immunoglobulin (IVIg) is used for replacement therapy in immunodeficiency states and for immunomodulation of various autoimmune diseases. Several case reports and series support a beneficial role of IVIg in systemic lupus erythematosus (SLE), both as salvage immunotherapy and in control of disease activity in general and amelioration of classical disease manifestations. Further, lupus nephritis can also be treated usually successfully with IVIg. A few questions remain unanswered as to the appropriate therapeutic dosage and the clinical manifestations that can be best treated with IVIg.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Sherer Y,Shoenfeld Y

doi

10.1016/j.autrev.2005.09.002

keywords:

subject

Has Abstract

pub_date

2006-02-01 00:00:00

pages

153-5

issue

2

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(05)00154-0

journal_volume

5

pub_type

杂志文章,评审
  • Factors influencing polyautoimmunity in systemic lupus erythematosus.

    abstract:OBJECTIVE:Since characterization of the extent to which particular combinations of autoimmune diseases (ADs) occur in excess of that expected by chance may offer new insights into possible common pathophysiological mechanisms, polyautoimmunity (i.e., ADs co-occurring within patients) in systemic lupus erythematosus (SL...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2009.10.001

    authors: Rojas-Villarraga A,Toro CE,Espinosa G,Rodríguez-Velosa Y,Duarte-Rey C,Mantilla RD,Iglesias-Gamarra A,Cervera R,Anaya JM

    更新日期:2010-02-01 00:00:00

  • The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis.

    abstract::Inflammatory muscle diseases (IMD), including dermatomyositis (DM) and polymyositis (PM), affect skeletal muscle, leading to profound tissue modification. The etiology of IMD is unknown, but multiple steps of the disease pathogenesis have been identified. The main alterations involve the immune response. Cellular infi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00055-1

    authors: Pignone A,Fiori G,Del Rosso A,Generini S,Matucci-Cerinic M

    更新日期:2002-08-01 00:00:00

  • COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

    abstract::The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term "hyperferritinemic syndromes" and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102573

    authors: Colafrancesco S,Alessandri C,Conti F,Priori R

    更新日期:2020-07-01 00:00:00

  • The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis.

    abstract::Inflammatory arthritides are chronic diseases characterised by an increase in cardiovascular risk, largely attributable to the synergy between high-grade systemic inflammation and an elevated prevalence of traditional cardiovascular risk factors. Amongst the latter, insulin resistance and type 2 diabetes (T2D) play a ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.11.030

    authors: Ursini F,Russo E,Ruscitti P,Giacomelli R,De Sarro G

    更新日期:2018-04-01 00:00:00

  • Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk?

    abstract::In patients with systemic auto-immune inflammatory rheumatic diseases (AIIRD) like rheumatoid arthritis the prevalence of cardiovascular disease (CVD) is increased. In the pathogenesis of AIIRD and atherosclerosis many similarities can be found in the process underlying CVD. Accumulation of inflammatory cells, in part...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.002

    authors: Jager NA,Teteloshvili N,Zeebregts CJ,Westra J,Bijl M

    更新日期:2012-07-01 00:00:00

  • Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.

    abstract:BACKGROUND:Cardiac neonatal lupus syndrome is due to anti-SSA or SSB antibodies and mainly includes congenital heart block (CHB) and dilated cardiomyopathy (DCM). Its optimal management is still debated. We report a large series of autoimmune high degree CHB. METHODS:Inclusion criteria in this retrospective study were...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.08.005

    authors: Levesque K,Morel N,Maltret A,Baron G,Masseau A,Orquevaux P,Piette JC,Barriere F,Le Bidois J,Fermont L,Fain O,Theulin A,Sassolas F,Pezard P,Amoura Z,Guettrot-Imbert G,Le Mercier D,Georgin-Lavialle S,Deligny C,Hachull

    更新日期:2015-12-01 00:00:00

  • Adaptive immune regulation in autoimmune diabetes.

    abstract::Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the loss of insulin-producing pancreatic β-cells. The pathogenesis of T1D is complex and multifactorial and involves a genetic susceptibility that predisposes to abnormal immune responses in the presence of ill-defined environmental insults to the ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.11.008

    authors: Ferretti C,La Cava A

    更新日期:2016-03-01 00:00:00

  • Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.

    abstract::New biologic agents have changed the paradigm of rheumatoid arthritis treatment, leading to improvement in managing patients' refractory to classical DMARDs. Anti-TNF-alpha is used as first-line treatment in patients failing to respond to classical DMARDs. However, up to 50% of patients fail to respond to these drugs ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2009.12.010

    authors: Caporali R,Sarzi-Puttini P,Atzeni F,Gorla R,Filippini M,Marchesoni A,Favalli EG,Bobbio-Pallavicini F,Montecucco C

    更新日期:2010-04-01 00:00:00

  • Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.

    abstract:BACKGROUND:The gold standard for secondary thromboprophylaxis in APS is long term anticoagulation with vitamin K antagonists (VKAs). Because of their widespread use and potential advantages of directs oral anticoagulants (DOACs) over VKAs, they have been prescribed in APS without definitive evidence of their safety and...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2020.102711

    authors: Dufrost V,Wahl D,Zuily S

    更新日期:2021-01-01 00:00:00

  • Infectome: a platform to trace infectious triggers of autoimmunity.

    abstract::The "exposome" is a term recently used to describe all environmental factors, both exogenous and endogenous, which we are exposed to in a lifetime. It represents an important tool in the study of autoimmunity, complementing classical immunological research tools and cutting-edge genome wide association studies (GWAS)....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.12.005

    authors: Bogdanos DP,Smyk DS,Invernizzi P,Rigopoulou EI,Blank M,Pouria S,Shoenfeld Y

    更新日期:2013-05-01 00:00:00

  • Non-redundant peptidomes from DAPs: towards "the vaccine"?

    abstract::Experimental analyses and literature survey reveal low-redundancy to the host proteins as a common denominator of immunogenic sequences mapped along tumor-, autoimmune-, and infectious disease-associated-proteins. The hypothesis that immunogenicity of peptide sequences is linked to proteomic redundancy is discussed. ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.09.004

    authors: Kanduc D,Lucchese A,Mittelman A

    更新日期:2007-04-01 00:00:00

  • Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry.

    abstract:OBJECTIVE:To investigate differences between childhood (cPAN)- and adult-onset polyarteritis nodosa (aPAN) patients. METHODS:cPAN patients' clinical findings at onset and outcomes were compared to those of aPAN patients from the French Vasculitis Study Group registry matched for year of enrollment and initial systemic...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.08.001

    authors: Iudici M,Quartier P,Pagnoux C,Merlin E,Agard C,Aouba A,Roblot P,Cohen P,Terrier B,Mouthon L,Guillevin L,Puéchal X,French Vasculitis Study Group.

    更新日期:2018-10-01 00:00:00

  • Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

    abstract::While the relationship between maternal connective tissue diseases and neonatal rashes was described in the 1960s and congenital heart block in the 1970s, the "culprit" antibody reactivity to the SSA/Ro-SSB/La ribonucleoprotein complex was not identified until the 1980s. However, studies have shown that approximately ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.07.013

    authors: Izmirly PM,Halushka MK,Rosenberg AZ,Whelton S,Rais-Bahrami K,Nath DS,Parton H,Clancy RM,Rasmussen S,Saxena A,Buyon JP

    更新日期:2017-09-01 00:00:00

  • Improving the effectiveness of autoantibody testing in the clinic.

    abstract::To enable clinicians to use autoantibody tests sensibly and economically, laboratories providing the test service have a responsibility to supply the test 'specifications'. This should include information about the test's validity and reliability, its normal range or range within a control population, its sensitivity ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00061-7

    authors: Sturgess A,Edmonds J

    更新日期:2002-10-01 00:00:00

  • Risk of scleroderma according to the type of immune checkpoint inhibitors.

    abstract:INTRODUCTION:Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. METHODS:To better characterize this irAE, our comprehensive approach combined the description of ICIs-induced scleroderma cases, the systematic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102596

    authors: Terrier B,Humbert S,Preta LH,Delage L,Razanamahery J,Laurent-Roussel S,Mestiri R,Beaudeau L,Legendre P,Goupil F,Hadjadj J,Stolzenberg MC,Treluyer JM,Westeel V,Valnet-Rabier MB,Wislez M,Mouthon L,Chouchana L

    更新日期:2020-08-01 00:00:00

  • Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.

    abstract::Analysis of autoantibodies (AAB) by indirect immunofluorescence (IIF) remains the hallmark of diagnosing autoimmune diseases despite the introduction of multiplex techniques. Non-organ specific AAB are screened in routine diagnostics by IIF on HEp-2 cells. However, IIF results vary due to objective (e.g., cell fixatio...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.02.033

    authors: Hiemann R,Büttner T,Krieger T,Roggenbuck D,Sack U,Conrad K

    更新日期:2009-09-01 00:00:00

  • P-glycoprotein in autoimmune diseases.

    abstract::Multidrug resistance-1 (MDR-1) is characterized by overfunction of P-glycoprotein (P-gp), a pump molecule that decreases intracellular drug concentration by effluxing them from the intracellular space. Broad ranges of structurally unrelated compounds are transported by P-gp, including antineoplastic agents, HIV protea...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2003.08.002

    authors: Richaud-Patin Y,Soto-Vega E,Jakez-Ocampo J,Llorente L

    更新日期:2004-03-01 00:00:00

  • Survivin in autoimmune diseases.

    abstract::Survivin is a protein functionally important for cell division, apoptosis, and possibly, for micro-RNA biogenesis. It is an established marker of malignant cell transformation. In non-malignant conditions, the unique properties of survivin make it indispensable for homeostasis of the immune system. Indeed, it is requi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.05.016

    authors: Gravina G,Wasén C,Garcia-Bonete MJ,Turkkila M,Erlandsson MC,Töyrä Silfverswärd S,Brisslert M,Pullerits R,Andersson KM,Katona G,Bokarewa MI

    更新日期:2017-08-01 00:00:00

  • Pathogenesis of immune thrombocytopenia.

    abstract::Immune thrombocytopenia (ITP) is a rare autoimmune disease due to an abnormal T cell response, notably supported by splenic T follicular helper cells, that stimulates the proliferation and differentiation of autoreactive B cells. The antiplatelet autoantibodies they produce facilitate platelet phagocytosis by macropha...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.04.012

    authors: Audia S,Mahévas M,Samson M,Godeau B,Bonnotte B

    更新日期:2017-06-01 00:00:00

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    abstract::The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, prec...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2014.03.002

    authors: Cervera R,Rodríguez-Pintó I,Colafrancesco S,Conti F,Valesini G,Rosário C,Agmon-Levin N,Shoenfeld Y,Ferrão C,Faria R,Vasconcelos C,Signorelli F,Espinosa G

    更新日期:2014-07-01 00:00:00

  • Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.

    abstract::Parkinson's disease, Alzheimer's disease and other neurodegenerative disorders share a common pathologic pathway with aggregation and deposition of misfolded proteins causing a disruption of particular neuronal networks. Several mechanisms have been implicated in the down-stream events following deposition of misfolde...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.04.010

    authors: Neff F,Wei X,Nölker C,Bacher M,Du Y,Dodel R

    更新日期:2008-06-01 00:00:00

  • Cardiomyopathy - An approach to the autoimmune background.

    abstract::Autoimmunity is increasingly accepted as the origin or amplifier of various diseases. In contrast to classic autoantibodies (AABs), which induce immune responses resulting in the destruction of the affected tissue, an additional class of AABs is directed against G-protein-coupled receptors (GPCRs; GPCR-AABs). GPCR-AAB...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.01.012

    authors: Becker NP,Müller J,Göttel P,Wallukat G,Schimke I

    更新日期:2017-03-01 00:00:00

  • Benefits and burden of the maternally-mediated immunological imprinting.

    abstract::The ontogenetic development of both the immune and the nervous system entirely depend on external environmental signals that induce a lifelong learning process. The resulting collective immunological knowledge about the external world is transmitted in an epi-genetic fashion to the offspring, but only from the materna...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.005

    authors: Lemke H,Tanasa RI,Trad A,Lange H

    更新日期:2009-03-01 00:00:00

  • CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

    abstract::There is strong evidence that a quantitative and/or functional deficiency in CD4+CD25+ regulatory T cells (T(reg) cells) plays a key role in the pathogenesis of many human autoimmune diseases. Therefore, targeting regulatory T cells with novel forms of immunotherapy should provide a means for successfully battling aut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2005.06.001

    authors: Beyersdorf N,Hanke T,Kerkau T,Hünig T

    更新日期:2006-01-01 00:00:00

  • Tools for critical appraisal of evidence in studies of diagnostic accuracy.

    abstract::Studies of accuracy are often more complex to understand than clinical trials, since there can be more than one outcome and scope (screening, diagnosis, and prognosis) and because results have to be reported in more than one way, than in clinical trials (relative risk or odds ratio). Sensitivity and specificity are co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2012.07.004

    authors: Giavarina D

    更新日期:2012-12-01 00:00:00

  • Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

    abstract::Dendritic cells (DCs) constitute a heterogeneous population of professional antigen presenting cells which are the initiators and key regulators for both immunity and tolerance induction. The significance and impact of DC biology in contemporary immunology and medical research is heightened by the award of the 2011 No...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.03.004

    authors: Chan VS,Nie YJ,Shen N,Yan S,Mok MY,Lau CS

    更新日期:2012-10-01 00:00:00

  • The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials.

    abstract::The impact of dietary interventions such as specific types of diet or nutritional supplements in rheumatoid arthritis (RA) has been subject to increased attention in recent years. The recognition of the unmet need to better understand the effects of specific dietary interventions on disease outcomes in RA, along with ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.007

    authors: Petersson S,Philippou E,Rodomar C,Nikiphorou E

    更新日期:2018-11-01 00:00:00

  • A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab.

    abstract::Approximately 500 treatment recalcitrant pemphigus vulgaris patients have been treated with rituximab. They were treated according to the lymphoma protocol (N=224) or rheumatoid arthritis protocol (RAP) (N=209) patients. Others were treated with modifications or combinations of the two. The mean duration of follow-up ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.12.002

    authors: Ahmed AR,Shetty S

    更新日期:2015-04-01 00:00:00

  • Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.

    abstract::Circulating antibodies specific to retinal proteins have been associated with retinal dysfunction in patients with retinopathy. Anti-recoverin antibodies found in patients with cancer-associated retinopathy (CAR) represent a unique model to study the relationship between retinal degeneration and autoimmunity. A body o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00127-1

    authors: Adamus G

    更新日期:2003-03-01 00:00:00

  • Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis.

    abstract:OBJECTIVE:Toll-like receptor (TLR) 4 (+896 A/G) gene polymorphism has been reported to be associated with susceptibility to giant cell arteritis (GCA) with inconsistent results. To provide a more definitive conclusion, a cumulative meta-analysis of the association of TLR4 (+896 A/G) polymorphism with GCA susceptibility...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2011.06.002

    authors: Alvarez-Rodriguez L,Muñoz Cacho P,Lopez-Hoyos M,Beares I,Mata C,Calvo-Alen J,Villa I,Martinez-Taboada VM

    更新日期:2011-10-01 00:00:00